Posts tagged as:

migraine

In the last few years, it seems that Zanaflex for migraine is becoming increasingly popular with specialists.  The name of the drug is tizanidine hydrochloride, with brand names such as Zanaflex and Sirdalud.  It’s considered a "muscle relaxant", and it acts on the central nervous system to relax certain muscles in your body.
Interestingly, Zanaflex is [...]

{ 2 comments }

Migraine Associated Vertigo Symptoms

by James on 2 March 2010

What exactly are migraine associated vertigo symptoms?  For that matter, what is migraine-associated vertigo (MAV)?  Is it a disease?  What causes it?  How is it treated?
Another term sometimes used is vestibular migraine.  But neither MAV or vestibular migraine are considered specific types of migraine (according to The International Classification of Headache Disorders).  So it better not [...]

{ 4 comments }

Don’t miss this interview from February with Dr. David W. Dodick, President-Elect of the American Headache Society.  He is interviewed by Dr. Thad Woodard on the live call-in show Line One on KSKA public radio.
The program is less than an hour long, and you can listen online or download the MP3.
The program hits some of [...]

{ 0 comments }

Should we give up on the PFO Closure Solution?

by James on 23 February 2010

At one time, the PFO closure seemed like one of the most hopeful treatments for migraine.  With a simple surgery, could your migraine attacks disappear?
PFO stands for patent foramen ovale, and the surgery closes a common "hole in the heart".  When some patients getting the surgery reported that their migraine attacks had gone away, research [...]

{ 0 comments }

In the past, doctors have encouraged women to avoid certain drugs, including triptans, Divalproex sodium, aspirin and ibuprofen, during pregnancy.  One of the reasons is because of the possibility of birth defects with certain medications.

Sometimes these concerns are well grounded in research.  But quite often they’re more a result of a lack of research.  We’re just [...]

{ 0 comments }